Back to Search Start Over

German drug companies are criticised for not focusing on useful therapeutic areas.

Authors :
Stafford N
Source :
BMJ (Clinical research ed.) [BMJ] 2015 Sep 15; Vol. 351, pp. h4938. Date of Electronic Publication: 2015 Sep 15.
Publication Year :
2015

Subjects

Subjects :
Cost Control
Drug Design
Drug Therapy economics
Germany
Humans
Rare Diseases drug therapy
Drug Industry economics
Drug Industry legislation & jurisprudence

Details

Language :
English
ISSN :
1756-1833
Volume :
351
Database :
MEDLINE
Journal :
BMJ (Clinical research ed.)
Publication Type :
Periodical
Accession number :
26374146
Full Text :
https://doi.org/10.1136/bmj.h4938
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details